ClinicalTrials.Veeva

Menu
D

Dermatologie Maldegem | Maldegem, Belgium

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Rocatinlimab
AMG 451
JNJ-77242113
secukinumab
Ustekinumab
Secukinumab
Ixekizumab
guselkumab
Ruxolitinib
Guselkumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 10 total trials

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (EMBARQ-CSU1)

The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urtic...

Enrolling
Chronic Spontaneous Urticaria
Biological: barzolvolimab
Biological: Matching placebo

The main purpose of this study is to assess how well JNJ-77242113 works when compared to placebo and ustekinumab in participants with moderate to sev...

Enrolling
Plaque Psoriasis
Drug: Ustekinumab
Drug: Matching Placebo to Ustekinumab

The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.

Enrolling
Atopic Dermatitis
Drug: Rocatinlimab
Other: Placebo

The purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children and adolescents (6 to \<18 Years Old) with moderate at...

Enrolling
Atopic Dermatitis
Drug: Vehicle Cream
Drug: Ruxolitinib

The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy and combination therapy treatment in adolescent parti...

Active, not recruiting
Atopic Dermatitis
Drug: Rocatinlimab
Drug: Placebo

Trial sponsors

Amgen logo
AbbVie logo
Celldex Therapeutics logo
G
Incyte logo
Janssen (J&J Innovative Medicine) logo
R

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems